Patient-to-Patient Transmission of Klebsiella pneumoniae Carbapenemase Variants with Reduced Ceftazidime-Avibactam Susceptibility

Authors:

Abstract
We report patient-to-patient transmission of Enterobacter hormaechei isolates with reduced susceptibility to ceftazidime-avibactam due to production of KPC-40, a variant of KPC-3 with a two-amino-acid insertion in the Ω-loop region (L167_E168dup). The index patient had received a prolonged course of ceftazidime-avibactam therapy, whereas the second patient had not received the agent and still became colonized with the KPC-40-producing strain.
Funding Information
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (K08AI114883, R03AI144636)
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI104895, R21AI135522)
  • HHS | NIH | National Eye Institute (R00EY028222)

This publication has 13 references indexed in Scilit: